CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,635,000 | +20.6% | 1,500,000 | +50.0% | 1.78% | +33.9% |
Q2 2021 | $6,330,000 | -47.5% | 1,000,000 | -31.0% | 1.33% | +37.6% |
Q2 2020 | $12,067,000 | +1025.7% | 1,448,604 | +936.8% | 0.96% | +761.6% |
Q1 2020 | $1,072,000 | -89.6% | 139,718 | -85.4% | 0.11% | -89.0% |
Q1 2019 | $10,310,000 | – | 959,077 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |